Evolus EOLS
NASDAQ EOLS
$8.01 +0.02 (+0.19%)
As of: Sep 30, 2026 · 3:40 PM EDT

Evolus (EOLS) Revenue (2019 - 2026)

Updated

Evolus (EOLS) posted Revenue of $84.08 million for Q2 2026, up 21.2% from $69.39 million a year earlier and up 15.0% from the prior quarter.

Analysis

Evolus (EOLS) Revenue (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Evolus was $316.49 million, up 13.9% year-over-year; for FY2025, it came in at $297.18 million, up 11.6% from FY2024.

  • Annual Revenue has increased for six consecutive years, with a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
  • In prior years, Evolus' Revenue was $266.27 million in FY2024 (+31.8%), $202.09 million in FY2023 (+36.0%), $148.62 million in FY2022 (+49.1%) and $99.67 million in FY2021 (+76.3%).
  • Quarterly Revenue has run from a low of $26.68 million in Q3 2021 to a high of $90.3 million in Q4 2025 over five years.
  • On a year-over-year basis, Revenue has increased in each of the last 25 quarters, with growth averaging 15.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Revenue ranged from 3.7% (Q2 2025) to 177.0% (Q1 2022).
  • According to Business Quant data, Revenue for the three prior quarters was $73.14 million (Q1 2026), $90.3 million (Q4 2025) and $68.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Evolus 527.45 Mn 335.14 Mn 57.18 Mn 84.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.08 Mn
Mar 31, 2026 73.14 Mn
Dec 31, 2025 90.30 Mn
Sep 30, 2025 68.97 Mn
Jun 30, 2025 69.39 Mn
Mar 31, 2025 68.52 Mn
Dec 31, 2024 78.95 Mn
Sep 30, 2024 61.09 Mn
Jun 30, 2024 66.91 Mn
Mar 31, 2024 59.33 Mn
Dec 31, 2023 61.00 Mn
Sep 30, 2023 50.02 Mn
Jun 30, 2023 49.35 Mn
Mar 31, 2023 41.72 Mn
Dec 31, 2022 43.65 Mn
Sep 30, 2022 33.90 Mn
Jun 30, 2022 37.16 Mn
Mar 31, 2022 33.91 Mn
Dec 31, 2021 34.66 Mn
Sep 30, 2021 26.68 Mn
API Access

Evolus Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=EOLS&period=max&api_key=YOUR_API_KEY